{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T07:51:04Z","timestamp":1794124264765,"version":"4.8.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.amjmed.2017.10.036","type":"journal-article","created":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T15:31:59Z","timestamp":1509982319000},"page":"269-275.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial"],"prefix":"10.1016","volume":"131","author":[{"given":"Meena P.","family":"Rao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragos","family":"Vinereanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Wojdyla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Atar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine M.","family":"Hylek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Wallentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato D.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard J.","family":"Gersh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Granger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.amjmed.2017.10.036_bib0010","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/heartjnl-2016-309832","article-title":"Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation","volume":"103","author":"Camm","year":"2017","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.amjmed.2017.10.036_bib0015","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/01.STR.0000209239.71702.ce","article-title":"Translating the results of randomized trials into clinical practice: the challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation","volume":"37","author":"Hylek","year":"2006","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.amjmed.2017.10.036_bib0020","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.amjmed.2012.01.033","article-title":"Risk of falls and major bleeds in patients on oral anticoagulation therapy","volume":"125","author":"Donz\u00e9","year":"2012","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.amjmed.2017.10.036_bib0025","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.amjmed.2014.05.035","article-title":"Prior history of falls and risk of outcomes in atrial fibrillation: the Loire Valley Atrial Fibrillation Project","volume":"127","author":"Banerjee","year":"2014","journal-title":"Am J Med"},{"issue":"9921","key":"10.1016\/j.amjmed.2017.10.036_bib0030","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomized trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.amjmed.2017.10.036_bib0035","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jacc.2016.06.034","article-title":"Edoxaban versus warfarin in atrial fibrillation patients at risk of falling: ENGAGE AF-TIMI 48 analysis","volume":"68","author":"Steffel","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.amjmed.2017.10.036_bib0040","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.amjmed.2017.10.036_bib0045","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ahj.2009.07.035","article-title":"Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale","volume":"159","author":"Lopes","year":"2010","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.amjmed.2017.10.036_bib0050","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.amjmed.2017.10.036_bib0055","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamacardio.2015.0345","article-title":"Incidence and determinants of traumatic intracranial bleeding among older veterans receiving warfarin for atrial fibrillation","volume":"1","author":"Dodson","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"5","key":"10.1016\/j.amjmed.2017.10.036_bib0060","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/MJT.0b013e3182546840","article-title":"Perceived or actual barriers to warfarin use in atrial fibrillation based on electronic medical records","volume":"19","author":"Rosenman","year":"2012","journal-title":"Am J Ther"},{"issue":"9","key":"10.1016\/j.amjmed.2017.10.036_bib0065","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1185\/03007995.2012.708653","article-title":"Why is warfarin underused for stroke prevention in atrial fibrillation? A detailed review of electronic medical records","volume":"28","author":"Rosenman","year":"2012","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"10.1016\/j.amjmed.2017.10.036_bib0070","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.amjmed.2005.02.022","article-title":"Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall","volume":"118","author":"Gage","year":"2005","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.amjmed.2017.10.036_bib0075","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ahj.2010.11.002","article-title":"Atrial fibrillation, anticoagulation, fall risk, and outcomes in elderly patients","volume":"161","author":"Sellers","year":"2011","journal-title":"Am Heart J"},{"issue":"7","key":"10.1016\/j.amjmed.2017.10.036_bib0080","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archinte.159.7.677","article-title":"Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls","volume":"159","author":"Man-Son-Hing","year":"1999","journal-title":"Arch Intern Med"},{"issue":"38","key":"10.1016\/j.amjmed.2017.10.036_bib0085","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"23","key":"10.1016\/j.amjmed.2017.10.036_bib0090","first-page":"e199","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.amjmed.2017.10.036_bib0095","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jacc.2016.07.714","article-title":"Atrial fibrillation and fall risk: what are the treatment implications?","volume":"68","author":"Hylek","year":"2016","journal-title":"J Am Coll Cardiol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293431731118X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293431731118X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:13:55Z","timestamp":1757582035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293431731118X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S000293431731118X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2017.10.036","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2017.10.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}